SEmalvac2 & SEmalvac Annual Meeting 2018

The annual meeting of the GHIT-funded SEmalvac2 and SEmalvac projects was successfully held on 29-30 May in Ouagadougou, Burkina Faso.

During the meeting, the project partners discussed the conduct of the ongoing BK-SE36/CpG phase 1b clinical trial (SEmalvac2) and agreed on the final activities of the BK-SE36 phase 1b clinical trial (SEmalvac) that was conducted in Banfora (Burkina Faso).

During their stay in Ouagadougou, the project partners also had the opportunity to visit the SEmalvac2 clinical trial site and the centre assigned for the long-term storage of the vaccine candidate and the trial samples. 

SEmalvac2 partners at the project annual meeting 29-30 May 2018, Ouagadougou, Burkina Faso